Participated · Equity · Feb 2025

Health Care Originals builds wearable devices that leverage acoustic technology and AI-driven edge computing to continuously monitor deep organ sounds and detect early signs of respiratory distress, often months before attacks. The company translates proprietary acoustic data into actionable, personalized insights for people with asthma and COPD. Among users, 100% report better sleep, 90% report reduced wheezing, and two-thirds experience zero asthma attacks within six months. HCO reports $5.5M in contracted annual recurring revenue (CARR), a robust IP portfolio of 14 granted and 10 pending patents, and says it is near-term profitable. Co-founder and CEO Sharon Samjitsingh, an asthma survivor, says the company intends to scale and seize a large market opportunity. HCO also offers public participation in its financing via Wefunder and positions its platform to improve patient outcomes while reducing healthcare costs.

Participated · Seed · Sep 2017

C2Sense is building the world’s largest digital olfactory platform to transform smell into real-time data for industrial Internet of Things applications. Its patented gas-sensing technology, developed by MIT founders including Tim Swager and CEO Jan Schnorr, can be designed to selectively detect a wide range of compounds. The sensors pair with a data platform and service so customers can access information and recommendations remotely; the technology is described as small, portable, and affordable for broad deployment. Cited use cases include estimating remaining shelf life to reduce food waste and monitoring toxic gases to protect workers. Founded in 2014 and based in Cambridge, Mass., C2Sense has drawn early traction across multiple applications. The company announced a $3.2 million seed round that management says will help accelerate connecting the real world of smell with digital data.